Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Giovanni Innella

University of Bologna

Research Interests

Explore related searches

Articles (20)

Collaborators (4)

Daniela Turchetti

Associate Professor of Medical Genetics

University of Bologna

Antonio De Leo

University of Bologna

Yuriko N Koyanagi

Aichi Cancer Center

Laura Cortesi

University of Modena and Reggio Emilia

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Giovanni Innella

Research Interests

Explore related searches

Articles (20)

Collaborators (4)

Daniela Turchetti

Antonio De Leo

Yuriko N Koyanagi

Laura Cortesi

Make your next move.

Giovanni Innella

Research Interests

Explore related searches

Articles (20)

Uptake of breast cancer risk-management strategies among unaffected BRCA 1/2 carriers: a systematic review of international evidence

BRCA1 and BRCA2 pathogenic variants increase the risk of four less common cancer types

A systematic review of cancer risks associated with MITF variants

Bilateral risk reducing mastectomy uptake trends in healthy BRCA1/2 mutation carriers of an European City, the brachoice study

Cascade testing as the missing link in cancer prevention among Lynch syndrome families

Low-Level Mosaicism in Tuberous Sclerosis Complex (TSC): Diagnostic and Clinical Implications From Two Novel Cases and Literature Review

Machine learning prediction of germline BRCA1/2 pathogenic variants in patients with ovarian cancer

Response to: Re: ‘Development of a risk score based on clinical–pathological features to predict the presence of germline BRCA1/2 pathogenic variants in ovarian cancer patients’

Development of a risk score based on clinical–pathological features to predict the presence of germline BRCA1/2 pathogenic variants in ovarian cancer patients

Clinical genetic services in the Emilia-Romagna region, Italy: current activity and open issues: a mixed-method study

Cancer prognosis and treatment results in patients with PTEN Hamartoma Tumour Syndrome (PHTS)-a European cohort study

The risk of a second primary cancer in PTEN Hamartoma Tumor Syndrome (PHTS)

Atypical cancer risk profile in carriers of Italian founder <i>BRCA1</i> variant p.His1673del: Implications for classification and clinical management

Unrecognised actionability for breast cancer risk variants identified in a national-level review of Australian familial cancer centres

Light and shade of multigene panel testing for hereditary cancer: Examples from the real world

Familial DMRT1-related non-obstructive azoospermia: a case report

Clinical implications of VUS reclassification in a single-centre series from application of ACMG/AMP classification rules specified for BRCA1/2

Long read sequencing on its way to the routine diagnostics of genetic diseases

Cancer Risks Associated With TP53 Pathogenic Variants: Maximum Likelihood Analysis of Extended Pedigrees for Diagnosis of First Cancers Beyond the Li-Fraumeni Syndrome Spectrum

Effectiveness and Impact of Transcript Analysis in Clinical Genetics Daily Practice

Collaborators (4)

Daniela Turchetti

Antonio De Leo

Yuriko N Koyanagi

Laura Cortesi

Make your next move.